R&D to Revenue
14.44%
Fiscal year · Period ending:

MMED R&D to Revenue
What is r&d to revenue?
R&D spending as percentage of revenue.
MMED r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 14.4423% | |
| 16.1326% | |
| 17.6995% | |
| 19.1091% |
Frequently asked questions: MMED r&d to revenue
What is MiniMed Group, Inc. (MMED)'s current r&d to revenue?
MiniMed Group, Inc. (MMED)'s latest reported r&d to revenue (Fiscal year) is 14.44% as of Apr 24, 2026. R&D spending as percentage of revenue.
How much historical r&d to revenue data is available for MMED?
Stock Alarm Pro provides 4 dated annual fiscal periods observations for MiniMed Group, Inc. (MMED)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare MMED's r&d to revenue to peers or set an alert?
You can open MMED's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on MMED delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance